Table 6.
Country | Liquid-based cytology | Core needle biopsy | Immunocytochemistry | Molecular or other testing |
---|---|---|---|---|
China | Not commonly used | No data | No data | Amplification refractory mutation system for BRAF V600E is the most popular technique. |
Next generation sequencing is not well accepted. | ||||
India | Has been used in some institutions as addition to conventional smears | Limited applicability and acceptability | Limited applicability and acceptability | Limited applicability and acceptability |
Japan | Used in some laboratories, but is not widely available | Rarely performed | No data | BRAF testing is uncommon practice and not covered by national health insurance system. |
Thyroglobulin and/or calcitonin in FNA needle washings is often used in thyroid or lymph node aspirates. | ||||
Korea | Became popular since 2010 | Widely used | Not routinely used but can be applied in specific cases | BRAF testing is used. |
Used in 68% institutions in 2016 | Thyroglobulin and/or calcitonin in FNA needle washings is often used in thyroid or lymph node aspirates. | |||
Philippines | Not used | No data | Rarely performed | Not covered by health care insurance |
Referred to outsource/abroad facilities if patients agree to pay | ||||
Taiwan | Became popular since 2014 | Rarely performed | In some institutions, immunocytochemical staining is used. | In some institutions, molecular testing is used. |
Thailand | Rarely used | Very uncommon | Available, but rarely performed | Rarely used due to limited availability |
FNA, fine-needle aspiration.